Latest Insider Transactions at Esperion Therapeutics, Inc. (ESPR)
This section provides a real-time view of insider transactions for Esperion Therapeutics, Inc. (ESPR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Esperion Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Esperion Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
197
-0.12%
|
$394
$2.17 P/Share
|
|
Oct 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
107
-0.07%
|
$214
$2.12 P/Share
|
|
Sep 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,608
-1.58%
|
$2,608
$1.78 P/Share
|
|
Sep 17
2024
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
14,550
-1.9%
|
$14,550
$1.8 P/Share
|
|
Aug 19
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
211
-0.13%
|
$211
$1.95 P/Share
|
|
Jul 17
2024
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
917
-0.33%
|
$1,834
$2.6 P/Share
|
|
Jul 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
108
-0.07%
|
$216
$2.59 P/Share
|
|
Jun 18
2024
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,285
-1.19%
|
$6,570
$2.87 P/Share
|
|
Jun 18
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,540
-1.51%
|
$5,080
$2.86 P/Share
|
|
May 23
2024
|
Jay Shepard Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+30.83%
|
-
|
|
May 23
2024
|
Stephen Rocamboli Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+38.81%
|
-
|
|
May 23
2024
|
Antonio M Jr Md D Phil Gotto Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+30.83%
|
-
|
|
May 23
2024
|
Alan Fuhrman Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+30.1%
|
-
|
|
May 23
2024
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+44.97%
|
-
|
|
May 23
2024
|
J Martin Carroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+26.24%
|
-
|
|
May 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
192
-0.11%
|
$384
$2.48 P/Share
|
|
Mar 14
2024
|
Eric Warren Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+37.27%
|
-
|
|
Mar 14
2024
|
Sheldon L. Koenig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
454,000
+37.19%
|
-
|
|
Mar 14
2024
|
Benjamin Looker General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+35.25%
|
-
|
|
Mar 14
2024
|
Joanne M. Foody Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+35.12%
|
-
|
|
Mar 14
2024
|
Benjamin Halladay Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
170,000
+41.07%
|
-
|
|
Sep 20
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
742
-1.07%
|
$742
$1.25 P/Share
|
|
Aug 18
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
243
-0.35%
|
$243
$1.41 P/Share
|
|
Jul 19
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
106
-0.15%
|
$106
$1.58 P/Share
|
|
Jun 21
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
603
-0.86%
|
$603
$1.48 P/Share
|
|
Jun 15
2023
|
Alan Fuhrman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+14.49%
|
-
|
|
Jun 15
2023
|
Antonio M Jr Md D Phil Gotto Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+15.26%
|
-
|
|
Jun 15
2023
|
Stephen Rocamboli Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+27.97%
|
-
|
|
Jun 15
2023
|
Jay Shepard Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+15.26%
|
-
|
|
Jun 15
2023
|
Nicole Vitullo Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+12.24%
|
-
|
|
Jun 15
2023
|
J Martin Carroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+11.0%
|
-
|
|
Jun 15
2023
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+50.0%
|
-
|
|
Jun 15
2023
|
Tracy M Woody Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+13.3%
|
-
|
|
May 17
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
219
-0.31%
|
$219
$1.62 P/Share
|
|
May 11
2023
|
J Martin Carroll Director |
BUY
Open market or private purchase
|
Direct |
23,091
+38.75%
|
$23,091
$1.57 P/Share
|
|
May 10
2023
|
Stephen Rocamboli Director |
BUY
Open market or private purchase
|
Direct |
8,111
+50.0%
|
$8,111
$1.5 P/Share
|
|
May 10
2023
|
J Martin Carroll Director |
BUY
Open market or private purchase
|
Direct |
8,409
+38.54%
|
$8,409
$1.49 P/Share
|
|
May 09
2023
|
Sheldon L. Koenig President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+6.01%
|
$20,000
$1.26 P/Share
|
|
Apr 19
2023
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
938
-0.73%
|
$938
$1.27 P/Share
|
|
Apr 19
2023
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
1,290
-1.52%
|
$1,290
$1.27 P/Share
|
|
Apr 19
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
115
-0.16%
|
$115
$1.28 P/Share
|
|
Mar 17
2023
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
526
-0.74%
|
$526
$1.78 P/Share
|
|
Mar 17
2023
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
6,999
-2.33%
|
$6,999
$1.78 P/Share
|
|
Mar 17
2023
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,808
-2.89%
|
$3,808
$1.78 P/Share
|
|
Mar 14
2023
|
Joanne M. Foody Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,750
+17.91%
|
-
|
|
Mar 14
2023
|
Benjamin Halladay Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+11.07%
|
-
|
|
Mar 14
2023
|
Sheldon L. Koenig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,000
+25.94%
|
-
|
|
Mar 14
2023
|
Eric Warren Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,300
+23.93%
|
-
|
|
Mar 14
2023
|
Benjamin Looker General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+19.44%
|
-
|
|
Mar 07
2023
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,884
-3.63%
|
$19,420
$5.07 P/Share
|